Results 181 to 190 of about 20,810 (232)
Some of the next articles are maybe not open access.
Chenodeoxycholic Acid and Ursodeoxycholic Acid
1990Cholelithiasis (gallstones) is a major medical and economic problem in the USA (Schoenfield, 1977; Schoenfield et al., 1981). It has been estimated to have a prevalence of 15 million women and five million men, and almost one million new cases are discovered each year (Ingelfinger, 1968; Friedman et al., 1966).
Robert A. Maxwell, Shohreh B. Eckhardt
openaire +1 more source
Chenodeoxycholic acid therapy in erythrohepatic protoporphyria
Journal of Hepatology, 1986The short-term effect of chenodeoxycholic acid administration on the excretion of protoporphyrin was investigated in 5 patients suffering from erythrohepatic protoporphyria. Faeces were collected for 7 days, 10 ml of bile was sampled daily and blood was drawn every 2 to 3 days.
J, Van Hattum +4 more
openaire +2 more sources
Polymorphism of chenodeoxycholic acid.
Il Farmaco; edizione scientifica, 1978Polymorphism of chenodeoxycholic acid was studied by differential thermal analysis and X-ray diffraction. Four polymorphic forms (three crystalline and one amorphous) were characterized.
G, Giuseppetti, M, Paciotti
openaire +1 more source
GALLSTONE DISSOLUTION BY CHENODEOXYCHOLIC ACID
The Lancet, 1973R H, Dowling, G D, Bell
openaire +4 more sources